Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
244.66%
0%
244.66%
6 Months
244.66%
0%
244.66%
1 Year
244.66%
0%
244.66%
2 Years
244.66%
0%
244.66%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Financière de Tubize SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
148.46%
EBIT to Interest (avg)
13.90
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
35.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.02%
ROE (avg)
7.93%
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
5.30
EV to EBIT
-3915.74
EV to EBITDA
-3917.02
EV to Capital Employed
5.31
EV to Sales
10256.45
PEG Ratio
18.58
Dividend Yield
0.00%
ROCE (Latest)
-0.14%
ROE (Latest)
9.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.00
-1.80
100.00%
Interest
0.00
2.00
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
88.20
85.20
3.52%
Operating Profit Margin (Excl OI)
0.00%
-223,626.90%
22,362.69%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 3.52% vs 1.91% in Dec 2022
About Financière de Tubize SA 
Financière de Tubize SA
Finance
Financiere de Tubize SA is a Belgium-based holding company. The Company holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States.
Company Coordinates 
Company Details
Allee de la Recherche 60 , BRUXELLES None : 1070
Registrar Details






